121 Aufrufe 121 0 Kommentare 0 Kommentare

    Edison issues report on The Biotech Growth Trust (BIOG)

    Für Sie zusammengefasst
    • Edison reports on The Biotech Growth Trust (BIOG).
    • Managers favor emerging biotech despite market challenges.
    • Belief in innovation era; sentiment expected to improve.

    Edison Investment Research Limited
    Edison issues report on The Biotech Growth Trust (BIOG)

    18-March-2025 / 15:47 GMT/BST
    The issuer is solely responsible for the content of this announcement.


     

    London, UK, 18 March 2025

     

    Edison issues report on The Biotech Growth Trust (BIOG)

    Edison issues report on The Biotech Growth Trust (LSE: BIOG)

    The Biotech Growth Trust’s (BIOG’s) highly experienced managers, Geoff Hsu and Josh Golomb, are able to draw on the considerable resources of global healthcare specialist OrbiMed. BIOG’s performance has been particularly challenging as the managers favour emerging (less mature) biotech companies, which have fared particularly poorly versus the S&P 500 during the longest and largest ever industry drawdown. Hsu and Golomb believe that biotech share price weakness is disconnected from industry fundamentals, as company valuations suggest an industry lacking in innovation, which has historically been the biggest driver of biotech performance. This seems incongruous as the managers believe we are in a ‘golden era of innovation’ with important technological and medical breakthroughs and a continued high number of new product approvals across multiple disease areas. They believe that sentiment towards the most innovative biotech companies, with robust clinical data, will improve and that BIOG’s portfolio is very well positioned to capture this move.

    Click here to read the full report.

    All reports published by Edison are available to download free of charge from its website

    www.edisongroup.com

    Edison is authorised and regulated by the Financial Conduct Authority.

    Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

    For more information, please contact Edison:

    enquiries@edisongroup.com

    +44 (0)20 3077 5700

    Connect with Edison on:

     

    LinkedIn www.linkedin.com/company/edison-group-/

    X  www.x.com/edison_inv_res

    YouTube www.youtube.com/edisonitv



    Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
    The issuer is solely responsible for the content of this announcement.


    End of Announcement - EQS News Service

    2102600  18-March-2025 





    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Edison issues report on The Biotech Growth Trust (BIOG) Edison Investment Research Limited Edison issues report on The Biotech Growth Trust (BIOG) 18-March-2025 / 15:47 GMT/BST The issuer is solely responsible for the content of this announcement.   London, UK, 18 March 2025   Edison issues report on The …